How did Innoviva's second-quarter revenue and net income compare to analysts' expectations? | INVA (Aug 06, 2025) | Candlesense

How did Innoviva's second-quarter revenue and net income compare to analysts' expectations?

Answer

Based on the excerpt you shared, the press release does not include the specific figures for Innoviva’s second‑quarter 2025 revenue, net income, or the analysts’ consensus estimates for those metrics. Consequently, I can’t determine from this text whether the company’s actual results were above, in line with, or below what analysts were expecting.

What you would need to know to answer the question

To compare Innoviva’s second‑quarter results to analysts’ expectations, the following pieces of information are required:

Metric What’s needed from the release What’s needed from analysts’ forecasts
Revenue The company’s reported Q2 2025 revenue (e.g., “$X million”) The consensus analyst estimate for Q2 2025 revenue (often reported as a range or a single figure in research reports)
Net Income The company’s reported Q2 2025 net income (e.g., “$Y million”) The consensus analyst estimate for Q2 2025 net income (or earnings per share, EPS)

With those numbers, the comparison is straightforward:

  • If the reported figure > analyst estimate → the result is *above expectations*
  • If the reported figure ≈ analyst estimate → the result is *in line with expectations*
  • If the reported figure < analyst estimate → the result is *below expectations*

Where to locate the missing data

  1. Full press release – The complete Business Wire announcement (often available on Innoviva’s investor‑relations website) will list the quarter’s revenue, net income, and sometimes a “beat” or “miss” commentary relative to analyst forecasts.
  2. Financial news services – Outlets such as Bloomberg, Reuters, or FactSet typically publish a “company beats/misses consensus estimates” summary that includes both the actual results and the analyst consensus.
  3. Analyst research reports – Brokerage houses (e.g., Jefferies, Baird, Stifel) that cover Innoviva often issue a pre‑release consensus estimate that can be found on market data platforms (e.g., Thomson Reuters, FactSet, S&P Capital IQ).

If you can provide the missing figures (e.g., “Innoviva reported $85 million in revenue versus analysts’ $78 million estimate, and net income of $12 million versus $9 million expected”), I can immediately give you a concise, data‑driven comparison. Otherwise, you’ll need to retrieve those numbers from the full release or a reliable financial‑news source.